Type 1 diabetes (Q28301396)

Type 2 diabetes: principles of pathogenesis and therapy

Europe PubMed Central

title

Type 1 diabetes (English)

0 references

0 references

Denis Daneman

1

0 references

language of work or name

English

0 references

publication date

11 March 2006

0 references

published in

The Lancet

0 references

volume

367

0 references

page(s)

847-58

0 references

issue

9513

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Lifetime Risk for Diabetes Mellitus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Genetics of Type 1A Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Type 1 diabetes: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Current knowledge of Japanese type 1 diabetic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Mechanisms of genetic susceptibility to type I diabetes: beyond HLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Type 1A diabetes induced by infection and immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Evidence for a food additive as a cause of ketosis-prone diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Environmental factors in the etiology of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Dietary intake of 10- to 16-year-old children and adolescents in central and northern Europe and association with the incidence of type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Childhood vaccination and type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Childhood immunizations and chronic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Natural course of insulin resistance in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

A missing link in the hygiene hypothesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Siblings, day-care attendance, and the risk of asthma and wheezing during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Skin test reactivity and number of siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The effect of day care exposure on the risk of developing type 1 diabetes: a meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Is the 'Accelerator Hypothesis' worthy of our attention?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The rise of childhood type 1 diabetes in the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish Childhood Type I Diabetes Registry Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Secular trends in overweight and obesity among Finnish adolescents in 1977-1999

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Type 1 diabetes among sardinian children is increasing: the Sardinian diabetes register for children aged 0-14 years (1989-1999)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

High Incidence of Childhood Type 1 Diabetes in the Avalon Peninsula, Newfoundland, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Comparative incidence of Type I diabetes in children aged under 15 years from South Asian and White or Other ethnic backgrounds in Leicestershire, UK, 1989 to 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Early diabetes-related complications in adolescents: risk factors and screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The effects of type 1 diabetes on cognitive performance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Specialist nurses in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cost and benefits of a multidisciplinary intensive diabetes education programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Insulins today and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Self-monitoring of blood glucose in children and teens with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Predictors of control of diabetes: monitoring may be the key.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Global harmonization of hemoglobin A1c

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Meta-analysis of the health effects of using the glycaemic index in meal-planning.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Hypoglycaemia unawareness and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Diverse causes of hypoglycemia-associated autonomic failure in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Detection of symptoms by adolescents and young adults with type 1 diabetes during experimental induction of mild hypoglycemia: role of hormonal and psychological variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Regression of microalbuminuria in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Incidence of end-stage renal disease in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Antihypertensive treatment and multifactorial approach for renal protection in diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

1 reference

7 January 2021

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Early vascular risk factor modification in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Diagnosis and management of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Waiting time limits proposed for specialist referral

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Risks and side effects of islet transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Five-year follow-up after clinical islet transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Artifactual insulin release from differentiated embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Metformin and insulin in type 1 diabetes: the first step

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Drugs on the horizon for diabesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Agents in development for the treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

A disease in motion: diabetes history and the new paradigm of transmuted disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

The effects of treatment on the direct costs of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021

Type 1 diabetes in the young: the harvest of sorrow goes on.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968341-4

7 January 2021